Markets are dropping off from record highs with Trump's tariffs in focus as key inflation data and earnings season loom.

First patient dosing in Company’s Phase 2b trial marks pivotal milestone in phage therapy development program targeting ...

Biodexa Announces Filing of CTA in Europe for Phase 3 Serenta Trial in Familial Adenomatous Polyposis (FAP) Biodexa ...

DCF analysis, a reliable and data-driven approach to estimating its intrinsic value. Instead of using future free cash flow as in the traditional DCF model, the GuruFocus DCF calculator uses EPS ...

Kenvue says that Thibaut Mongon is leaving as CEO as the maker of Listerine and Band-Aid brands continues with a strategic ...

Canada's Bombardier is renowned for private jets which offer zippy yet smooth performance. With a range of 5,900 nautical ...

Almonty Industries Inc. ("Almonty" or the "Company") (TSX: AII) (ASX: AiiDA) (OTCQX: ALMTF) (Frankfurt: ALI1), a leading global producer of tungsten concentrate, announced today the pricing of its ...

Low-cost carrier Wizz Air said on Monday that it plans to suspend all locally based flight operations out of Abu Dhabi as ...

President Donald Trump and his allies are focusing on Jerome Powell's handling of an expensive renovation of the Federal Reserve's headquarters as a new way to scrutinize Powell's leadership at the ...

Palantir (PLTR) shares are up nearly 90% so far this year. Wedbush Securities managing director and global head of technology ...

President Trump claimed that the U.S. made $25 billion last month, which he partially credited to tariffs.

The FTSE 100 (^FTSE) ticked higher and European stocks dropped on Monday morning, as traders digest the latest round of ...